| 1 |
Liu Y, Liu X, Lin C, et al. Noncoding RNAs regulate alternative splicing in Cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 11.
|
| 2 |
Liu Z, Rabadan R. Computing the role of alternative splicing in cancer[J]. Trends Cancer, 2021, 7(4): 347-358.
|
| 3 |
Wu S, Wang J, Zhu X, et al. The functional impact of alternative splicing on the survival prognosis of triple-negative breast cancer[J]. Front Genet, 2020, 11: 604262.
|
| 4 |
Shimamoto A, Kitao S, Ichikawa K, et al. A unique human gene that spans over 230 kb in the human chromosome 8p11-12 and codes multiple family proteins sharing RNA-binding motifs[J]. Proc Natl Acad Sci USA, 1996, 93(20): 10913-10917.
|
| 5 |
Yabana T, Hooper ML, Farrell SR, et al. GCaMP3 expressing cells in the ganglion cell layer of Thy1-GCaMP3 transgenic mice before and after optic nerve injury[J]. Exp Eye Res, 2021, 202: 108297.
|
| 6 |
Akerberg AA, Burns CE, Burns CG. Exploring the activities of RBPMS proteins in myocardial biology[J]. Pediatr Cardiol, 2019, 40(7): 1410-1418.
|
| 7 |
Fu J, Cheng L, Wang Y, et al. The RNA-binding protein RBPMS1 represses AP-1 signaling and regulates breast cancer cell proliferation and migration[J]. Biochim Biophys Acta, 2015, 1853(1): 1-13.
|
| 8 |
Parang B, Barrett CW, Williams CS. AOM/DSS model of colitis-associated cancer[J]. Methods Mol Biol, 2016, 1422: 297-307.
|
| 9 |
Liu X, Wei W, Li X, et al. BMI1 and MEL18 promote colitis-associated cancer in mice via REG3B and STAT3[J]. Gastroenterology, 2017, 153(6): 1607-1620.
|
| 10 |
De Robertis M, Massi E, Poeta ML, et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies[J]. J Carcinog, 2011, 10: 9.
|
| 11 |
Oltean S, Bates DO. Hallmarks of alternative splicing in cancer[J]. Oncogene, 2014, 33(46): 5311-5318.
|
| 12 |
Soo V, Swadling JB, Faure AJ, et al. Fitness landscape of a dynamic RNA structure[J]. PLoS Genet, 2021, 17(2): e1009353.
|
| 13 |
Black DL. Mechanisms of alternative pre-messenger RNA splicing[J]. Annu Rev Biochem, 2003, 72: 291-336.
|
| 14 |
Wang Y, Chen D, Qian H, et al. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression[J]. Cancer Cell, 2014, 26(3): 374-389.
|
| 15 |
Stevens M, Oltean S. Modulation of the apoptosis gene Bcl-x function through alternative splicing[J]. Front Genet, 2019, 10: 804.
|
| 16 |
Weldon C, Dacanay JG, Gokhale V, et al. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X[J]. Nucleic Acids Res, 2018, 46(2): 886-896.
|
| 17 |
Francies FZ, Bassa S, Chatziioannou A, et al. Splicing genomics events in cervical cancer: Insights for phenotypic stratification and biomarker potency[J]. Genes (Basel), 2021, 12(2).
|
| 18 |
Jiang J, Chen X, Liu H, et al. Erratum: Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM[J]. Am J Cancer Res, 2021, 11(1): 297-300.
|
| 19 |
Sciarrillo R, Wojtuszkiewicz A, Assaraf YG, et al. The role of alternative splicing in cancer: From oncogenesis to drug resistance[J]. Drug Resist Updat, 2020, 53: 100728.
|
| 20 |
Rastgoo N, Pourabdollah M, Abdi J, et al. Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS[J]. Leukemia, 2018, 32(11): 2471-2482.
|
| 21 |
Baez-Vega PM, Echevarria VI, Valiyeva F, et al. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells[J]. Oncotarget, 2016, 7(24): 36321-36337.
|
| 22 |
Baughn LB, Di Liberto M, Niesvizky R, et al. CDK2 phosphorylation of Smad2 disrupts TGF-beta transcriptional regulation in resistant primary bone marrow myeloma cells[J]. J Immunol, 2009, 182(4): 1810-1817.
|
| 23 |
Sun Y, Ding L, Zhang H, et al. Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS[J]. Nucleic Acids Res, 2006, 34(21): 6314-6326.
|